Submitted by Anonymous (not verified) on 18 December 2025 - 9:56
Human medicines European public assessment report (EPAR): Alyftrek, deutivacaftor / tezacaftor / vanzacaftor, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised
Source: